在患有先天性心脏病的患者中,药剂师管理的抗凝计划的实用性
Meredith J O'Neil1, BreAnn N Garr1, Jenna M Faircloth2
1Division of Pharmacy, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Cardiology in the young
|September 8, 2023
概括
一个由药剂师管理的抗凝剂计划显著改善了儿科心脏病患者的华法林管理,在9年内,治疗范围的时间增加了15%. 这种一致的模型提高了先天性心脏病 (CHD) 的儿童的临床结果.
科学领域:
- 心脏病学 心脏病学
- 药理学 药理学是指药理学的学科.
- 儿科医学 儿科医学
背景情况:
- 华法林是患有先天性心脏病 (CHD) 的患者的关键抗凝剂.
- 华法林治疗的管理可能是复杂的,需要优化护理模式.
- 从一个多学科到一个集中制药师领导的抗凝团队的转变被实施.
研究的目的:
- 用于描述由中央集中的抗凝计划管理的患者队列.
- 评估药剂师管理模型对华法林治疗有效性的影响.
- 评估治疗范围 (TTR) 的时间改善,作为临床结果的标志物.
主要方法:
- 一个单一中心的回顾性队列研究设计.
- 在实施药剂师管理模型之前和之后的TTR比较.
- 用于对TTR数据的统计分析的配对t测试.
主要成果:
- 药剂师管理模型的实施将TTR从65.7%提高到80.2% (p < .001).
- 从2013年到2022年,TTR的显著改善一直持续.
- 2022年队列包括119名患者,主要是机械置换患者 (68%).
结论:
- 一个协作式,集中式,药剂师管理的模型可以改善心脏病患者的华法林管理.
- 这种做法的改变导致了在9年内,TTR持续增加了15%.
- 药剂师主导的模型证明了儿科抗凝治疗的改善临床结果.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
747
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
747
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
559
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
559
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Cardiac Catheterization I: Pre-Procedure Overview
56
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
56


